People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Seranova Bio, Inc. | — | Biotechnology | Series A | $15.0M | $64.1M | 2024 |
| Topo Therapeutics, Inc. | — | Biotechnology | Series A | $10.6M | $44.3M | 2024 |
Hui Tian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hui Tian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| LEON CHEN | 1 | 15 |
| Jim Tananbaum | 1 | 4 |
| Aaron Ring | 1 | 3 |
| Beatrice McQueen | 1 | 2 |
| James Jeffrey Goater, Jr. | 1 | 1 |
| Damien Soghoian | 1 | 1 |
| Sabah Oney | 1 | 1 |
| Bruce Jeffrey Bean | 1 | 1 |
| Madgalene Moran | 1 | 1 |
| Karin Jeffrey Kleinhans | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.